VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,846,868 | -5.9% | 291,597 | +5.3% | 2.75% | -10.0% |
| Q2 2023 | $8,337,565 | -7.0% | 276,904 | -0.1% | 3.06% | -11.6% |
| Q1 2023 | $8,964,429 | +14.1% | 277,108 | +1.1% | 3.46% | +5.5% |
| Q4 2022 | $7,856,767 | +18.8% | 274,137 | -0.0% | 3.28% | +1.7% |
| Q3 2022 | $6,613,000 | +0.4% | 274,162 | +9.3% | 3.22% | +1.6% |
| Q2 2022 | $6,586,000 | -36.5% | 250,818 | -7.3% | 3.17% | -30.0% |
| Q1 2022 | $10,373,000 | +32.4% | 270,473 | +10.6% | 4.53% | +27.9% |
| Q4 2021 | $7,832,000 | +7.1% | 244,524 | -1.4% | 3.54% | -1.6% |
| Q3 2021 | $7,310,000 | -9.1% | 248,050 | +4.8% | 3.60% | -12.2% |
| Q2 2021 | $8,046,000 | +48.7% | 236,779 | +42.2% | 4.10% | +22.2% |
| Q1 2021 | $5,410,000 | -3.3% | 166,465 | +7.2% | 3.36% | +27.4% |
| Q4 2020 | $5,592,000 | – | 155,244 | – | 2.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |